Pharmacy chains activity analysis

Pharmacy chains activity analysis

Russian pharmaceuticals retail chain segment evaluation, both on the level of the state and in particular regions. Pharmacy chains development forecast


Product sales and separate market development forecast, based on unique mathematical models

Business and marketing plan development

Development of detailed business-plans, required to evaluate the reasonability of project start

Search of partners for contract production in Russia

Potential partners search and evaluation, based on their technical opportunities, appropriate experience, and reputation

Monitoring of import substitution

assessment of the main trends of import substitution policies and localization processes in the pharmaceutical market in Russia, the key beneficiaries and companies at risk


2/7/2024 RNC Pharma: Share of US Veterinary Manufacturers in Retail Market Drops 6%

In 2023, 35.4 billion rubles’ worth of veterinary drugs were sold on the Russian retail market (retail prices, VAT included), up 22.5% from 2022, which is record-worthy. In physical terms, 235 million minimum dosage units (MDU) were sold, up 13%. The difference in growth rates can be easily explained by the inflation rate. Interestingly, the online market continued to actively develop—online sales went up 2.2 times in MDUs, while offline sales grew by only 5%.

2/6/2024 RNC Pharma: Most Expensive Glucose Meters Sold in North Caucasus, Most Expensive Test Strips in Far East

In 2023, 1.38 million glucose meters and around 657.3 million glucose test strips were sold on the Russian retail market, down 0.3% and 3.5% from 2022, respectively.

2/2/2024 RNC Pharma: Russian Consumers of Nebulizers Prefer Marketplaces to Pharmacies, Except in Far East

In 2023, 4.9 billion rubles’ worth of nebulizers were sold on the Russian retail market (retail prices, VAT included), up only 0.5% from 2022. At the same time, the sales in physical terms went up by as much as 9.6%. Online sales alone contributed to the total growth rates, with its 40.4% in monetary terms and 67.6% in physical terms.

2/1/2024 Pharmaceutical Drug Production in Russia in 2023

In 2023, Russian manufacturers produced 716.5 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 7.2% from 2022. In physical terms, it was 4.09 billion packages, down 2% from 2022.

1/31/2024 RNC Pharma: More Than 6M Blood Pressure Monitors Sold in Russia in 2023, Up 29%

In 2023, around 6.03 million of all types of blood pressure monitors worth 11.87 billion rubles (retail prices, VAT included) were sold in the offline and online retail market in Russia.

1/19/2024 Inflation Rates in the Russian Pharmaceutical Retail Market in January–November 2023

In January–November 2023, veterinary drugs on the Russian retail market went up in price 26.5% from the same period in 2022.

9/29/2023 Study by RNC Pharma and Medvestnik: More than 90% of Russian Doctors Support Simpler Accreditation

Almost half of the respondents, 49.5%, believe that this change is long overdue, since most doctors view accreditation as nothing more than a bureaucratic procedure. Another 22.8% say that the current approaches to personnel policy in healthcare should be changed completely.

9/28/2023 Pharmaceutical Drug Production in Russia (August 2023)

In January–August 2023, Russian manufacturers produced 455.8 billion rubles’ worth of ready-made pharmaceutical drugs (manufacturer’s prices, VAT included), up 0.9% from the same period last year, which is the first positive growth rate since January 2023. In physical terms, the production volume was 2.61 billion packages, down 5.3% from January–August 2022, or 51.4 billion minimum dosage units (MDUs), down 2.4%.

8/24/2023 Pharmaceutical Drug Production in Russia (July 2023)

From January to July 2023, Russian manufacturers produced 398.6 billion rubles’ worth of ready-made drugs (manufacturer’s prices, VAT included), down 0.3% from the same period in 2022. In physical terms, 2.26 billion packages were produced, down 6.9% from January–July 2022. If calculated in minimum dosage units (MDU), the production volume was 44.8 billion, down 2.3%.

8/21/2023 RNC Pharma: Pharmaceutical Logistics Operators Deal with Shortages of Storage Capacities and Experienced Personnel

Comprehensive ranking of logistics operators in the Russian pharmaceutical market in 2022.